Multiple Reaction Monitoring of Multiple Low-Abundance Transcription Factors in Whole Lung Cancer Cell Lysates

Authors
Kim, Jun SeokLee, YoungjuLee, Min YoungShin, JihyeHan, Jung MinYang, Eun GyeongYu, Myeong-HeeKim, SunghoonHwang, DaeheeLee, Cheolju
Issue Date
2013-06
Publisher
AMER CHEMICAL SOC
Citation
JOURNAL OF PROTEOME RESEARCH, v.12, no.6, pp.2582 - 2596
Abstract
Lung cancer-related transcription factors (TFs) were identified by integrating previously reported genomic, transcriptomic, and proteomic data and were quantified by multiple reaction monitoring (MRM) in various cell lines. All experiments were performed without affinity depletion or subfractionation of cell lysates. Since the target proteins were expected to be present in low abundance, we experimentally optimized MRM transition parameters with chemically synthesized peptides. Quantitation was based on stable isotope-labeled standard peptides (SIS peptides). Out of 288 MRM measurements (36 peptides representing 28 TFs x 8 cell lines), 241 were successfully obtained within a quantitation limit of 15 amol, 221 measurements (91.7%) showed coefficients of variation (CVs) of <= 20%, and 149 (61.8%) showed CVs of <= 10%, quantifying as low as 19.4 amol/mu g protein for STAT2 with a CV of 6.3% in an A549 cell. Comparisons between MRM measurements and levels of the corresponding mRNAs revealed linear, nonlinear, or no relationship between protein and mRNA levels, indicating the need for an MRM assay. An integrative analysis of MRM and gene expression profiles from doxorubicin-resistant H69AR and sensitive H69 cells further showed that 14 differentially expressed TFs, such as STAT1 and SMAD4, regulated genes associated with drug resistance and cell differentiation-related processes. Thus, the analytical performance of MRM for the quantitation of low abundance TFs suggests its usefulness for biological application.
Keywords
GENE-EXPRESSION; MASS-SPECTROMETRY; DRUG-RESISTANCE; PROTEINS; ADENOCARCINOMA; IDENTIFICATION; DOXORUBICIN; IMMUNOASSAY; CARCINOMAS; MUTATIONS; GENE-EXPRESSION; MASS-SPECTROMETRY; DRUG-RESISTANCE; PROTEINS; ADENOCARCINOMA; IDENTIFICATION; DOXORUBICIN; IMMUNOASSAY; CARCINOMAS; MUTATIONS; TF; MRM; transition parameters; doxorubicin; drug-resistance
ISSN
1535-3893
URI
https://pubs.kist.re.kr/handle/201004/128021
DOI
10.1021/pr3011414
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE